financetom
Business
financetom
/
Business
/
US FDA approves Adaptimmune's gene therapy for rare cancer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Adaptimmune's gene therapy for rare cancer
Aug 2, 2024 6:33 AM

Aug 2 (Reuters) - The U.S. Food and Drug Administration

said on Friday it has approved Adaptimmune's

first-of-its-kind gene therapy to treat adult patients with a

type of advanced synovial sarcoma who have received prior

chemotherapy.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved